APTX — Apotex Health Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge CapNeutral

Annual income statement for Apotex Health, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.

	2024 March 31st	2025 March 31st	2026 March 30th	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	PROSPECTUS
Standards:	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final
Revenue
Total Revenue	2,940	3,350	—	3,491
Cost of Revenue
Gross Profit	1,103	1,794	—	1,942
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	2,945	2,797	—	2,705
Operating Profit	-4.66	552	—	786
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-156	311	—	520
Provision for Income Taxes
Net Income After Taxes	-147	152	—	374
Net Income Before Extraordinary Items
Net Income	-147	152	—	374
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-147	152	—	374
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.083	1.17	—	2.58
Dividends per Share